Ticker Details
Rapport Therapeutics, Inc. Common Stock
IPO Date:	June 7, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.8B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.83 | 4.14%
Avg Daily Range (30 D):	$0.98 | 2.68%
Avg Daily Range (90 D):	$0.80 | 2.54%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.29M
Avg Daily Volume (90 D):	.27M

Trade Size
Avg Trade Size (Sh.):	56
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	48

Institutional Trades
Total Institutional Trades:	369
Avg Institutional Trade:	$1.55M
Avg Institutional Trade (30 D):	$1.48M
Avg Institutional Trade (90 D):	$1.29M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.93M
Avg Closing Trade (30 D):	$1.65M
Avg Closing Trade (90 D):	$1.45M
Avg Closing Volume:	75.59K

News

Apr 1, 2026 @ 11:00 AM Rapport Therapeutics to Present New Phase 2 Treatm... Source: Na

Sep 10, 2025 @ 1:17 AM Rapport Announces Pricing of Public Offering of Co... Source: Globe Newswire

Jun 12, 2025 @ 8:22 PM Analysts Can't Get Enough of These Little-Known Bi... Source: Marketbeat.Com

Jun 2, 2025 @ 6:45 PM Rapport Therapeutics Hosts Investor and Analyst Da... Source: Rapport Therapeutics, Inc.

Mar 21, 2025 @ 11:00 AM Rapport Therapeutics to Present Data at the 2025 A... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.59	$-.42	$-.71
Diluted EPS	$-2.59	$-.42	$-.71
Revenue	$20M	$20M	$M
Gross Profit
Net Income / Loss	$-107.28M	$-19.86M	$-33.76M
Operating Income / Loss	$-122.21M	$-24.22M	$-38.51M
Cost of Revenue
Net Cash Flow	$20.45M	$25.41M	$-198.71M
PE Ratio